Example sentences of "colitis and [noun] ['s] [noun] " in BNC.

  Next page
No Sentence
1 A confident distinction between ulcerative colitis and Crohn 's colitis is not possible in all patients despite adequate clinical and pathological evaluation and many are classified as having indeterminate colitis .
2 To investigate the mode of inheritance of ulcerative colitis and Crohn 's disease by complex segregation analysis .
3 In a regional study including about 10% of the Danish population we found the population relative risk of ulcerative colitis and Crohn 's disease among first degree relatives of patients with either disease to be about 10 , which strongly suggests that these disorders have a genetic cause .
4 The annual incidence of ulcerative colitis and Crohn 's disease in this region was estimated for the years 1962 to 1978 and the prevalences on 31 December 1978 were calculated .
5 The diagnostic criteria for ulcerative colitis and Crohn 's disease in the probands have been described .
6 In a previous paper we estimated that the sex and age standardised population relative risk for ulcerative colitis and Crohn 's disease was about 10 among first degree relatives of probands with ulcerative colitis and Crohn 's disease .
7 In a previous paper we estimated that the sex and age standardised population relative risk for ulcerative colitis and Crohn 's disease was about 10 among first degree relatives of probands with ulcerative colitis and Crohn 's disease .
8 Thus a considerable number of cases of both ulcerative colitis and Crohn 's disease are sporadic or non-genetic .
9 They performed a mixed model analysis by fitting several mathematical models to the segregation of ulcerative colitis and Crohn 's disease in a series of Danish families .
10 The reported recurrence risk ratios ( λ R ) , which are defined by the risk to a relative of class R ( K R ) divided by the population prevalence ( K p ) , fit a multifactorial model better than a monogenic model for both ulcerative colitis and Crohn 's disease ( see table ; note that recurrence risks corrected for sex and age are not available to permit rigorous analysis of these data ) .
11 Systemic endotoxaemia has been demonstrated in ulcerative colitis and Crohn 's disease and correlates with the extent and activity of disease .
12 At present , little is known about the role of platelet activating factor in ulcerative diseases of the gastrointestinal tract in man , although it has been reported in mucosal biopsy specimens from patients with ulcerative colitis and Crohn 's disease .
13 Ulcerative colitis and Crohn 's disease are chronic , remitting and relapsing mucosal disorders , collectively known as inflammatory bowel disease .
14 The established mucosal lesion in ulcerative colitis and Crohn 's disease is dominated by terminally differentiated B cells appearing as plasma cells and blasts .
15 Our laboratory has recently shown significant disparity between ulcerative colitis and Crohn 's disease in terms of IgG subclass production in the mucosal lesion ; the proportion of IgG1 immunocytes was found to be higher in ulcerative colitis than in Crohn 's colitis , while the reverse was true for the IgG2 cell fraction .
16 The dissimilar IgG subclass distribution between ulcerative colitis and Crohn 's disease might reflect different antigenic or mitogenic exposures in the gut .
17 Ulcerative colitis and Crohn 's disease belong to the group of idiopathic inflammatory bowel diseases and could theoretically be extremes of the same disease .
18 Study of indium-111 labelled neutrophils shows close similarities between ulcerative colitis and Crohn 's disease in respect of the quantity and kinetics of neutrophil migration from blood to lumen across the intestinal mucosa .
19 In an attempt to localise , in vivo , the site of neutrophil chemoattractants in patients with ulcerative colitis and Crohn 's disease , we used a dual isotope method to quantitate simultaneously intestinal inflammation and blood loss .
20 The different results obtained in this study in patients with ulcerative colitis and Crohn 's disease agrees with many clinical and experimental observations .
21 Each case was also evaluated and graded for 23 individual histological features ( Table IV ) , mostly those considered useful in the differential diagnosis of ulcerative colitis and Crohn 's disease , but including others that were added in the search for histological features that might distinguish RP from controls .
22 In both ulcerative colitis and Crohn 's disease , immunological mechanisms seem to play a role in either perpetuating or increasing the inflammatory response .
23 Several studies have shown the efficacy of 6-mercaptopurine and azathioprine in the treatment of both ulcerative colitis and Crohn 's disease .
24 Plasma fatty acid patterns in patients with ulcerative colitis and Crohn 's disease were similar .
25 Plasma percentages of the different fatty acids in patients with ulcerative colitis and Crohn 's disease are shown in Tables II and III .
26 The most striking result of this study is the increased plasma concentrations of the precursor ( α-linolenic acid ) and the end product ( docosahexaenoic acid ) of the n3 polyunsaturated fatty acid series in active ulcerative colitis and Crohn 's disease .
27 This was especially marked for long chain n6 polyunsaturated fatty acids in ulcerative colitis and Crohn 's disease .
28 In this context , the similar polyunsaturated fatty acids pattern found in ulcerative colitis and Crohn 's disease suggests that both diseases might share a common pathogenic mechanism .
29 However , epithelial HLA-DR is induced in inflammatory conditions including ulcerative colitis and Crohn 's disease .
30 Giaffer and colleagues have recently used a slightly modified buccal cell adhesion assay to show that E coli from ulcerative colitis and Crohn 's disease patients were significantly more adhesive than isolates from a control group , but thiat this property was independent of disease activity , anatomical site and treatment .
  Next page